| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.00B | 3.04B | 3.26B | 3.79B | 3.53B | 3.15B |
| Gross Profit | 414.50M | 408.65M | 399.05M | 449.24M | 426.52M | 350.72M |
| EBITDA | 135.17M | 132.60M | 140.88M | 164.50M | 155.06M | 104.76M |
| Net Income | 74.45M | 71.55M | 77.06M | 89.81M | 88.80M | 10.79M |
Balance Sheet | ||||||
| Total Assets | 1.72B | 1.79B | 1.78B | 2.07B | 1.94B | 1.67B |
| Cash, Cash Equivalents and Short-Term Investments | 124.92M | 126.16M | 185.46M | 36.18M | 37.99M | 62.72M |
| Total Debt | 7.87M | 147.11M | 153.96M | 343.58M | 288.75M | 164.01M |
| Total Liabilities | 802.94M | 879.20M | 854.78M | 1.16B | 1.13B | 940.49M |
| Stockholders Equity | 914.03M | 906.41M | 924.25M | 905.30M | 806.53M | 731.19M |
Cash Flow | ||||||
| Free Cash Flow | 82.42M | 104.06M | 363.09M | -45.75M | -131.20M | 138.58M |
| Operating Cash Flow | 90.73M | 112.35M | 371.65M | -35.77M | -124.35M | 140.94M |
| Investing Cash Flow | -5.56M | -62.39M | 9.04M | -8.26M | -3.72M | 31.93M |
| Financing Cash Flow | -107.22M | -110.91M | -227.77M | 39.53M | 108.11M | -148.32M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $1.52B | 18.15 | 9.30% | 1.02% | 3.19% | -4.91% | |
71 Outperform | $5.24B | 25.80 | 4.71% | 2.77% | -2.30% | -29.75% | |
71 Outperform | $13.27B | 16.20 | 9.95% | 1.15% | 6.95% | 19.19% | |
68 Neutral | $972.71M | 13.82 | 8.11% | ― | -4.88% | 2.57% | |
64 Neutral | $7.11B | 15.23 | 7.70% | ― | 3.16% | 1.09% | |
62 Neutral | $2.53B | 19.04 | 8.51% | ― | -6.69% | -51.74% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |
On February 5, 2026, ScanSource reported results for the second quarter ended December 31, 2025, posting a 2.5% year-over-year increase in net sales to $766.5 million and a 1.2% rise in gross profit to $102.9 million, even as gross margin, operating income and non-GAAP profitability declined modestly. Recurring revenue grew 15.9% year-over-year and accounted for a larger share of gross profit, while adjusted EBITDA and non-GAAP net income fell compared with the prior-year period; the company generated strong operating and free cash flow, held modest net debt, and repurchased $38.7 million of shares during the first half of fiscal 2026. In a parallel move to refine its governance structure, the board appointed Charles A. Mathis as lead independent director and chair of the nominating and corporate governance committee, with Vernon J. Nagel taking over as audit committee chair, while longtime director Peter C. Browning remained on the board and all committees, signaling continuity alongside refreshed oversight for investors and other stakeholders.
The most recent analyst rating on (SCSC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on ScanSource stock, see the SCSC Stock Forecast page.
The filing excerpt from ScanSource provides only a cross-reference statement indicating that information disclosed in another section is incorporated by reference, without offering substantive details about the company’s operations, the nature of the transaction, or its impact on stakeholders.
The most recent analyst rating on (SCSC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on ScanSource stock, see the SCSC Stock Forecast page.
On December 9, 2025, ScanSource, Inc. held its annual meeting of shareholders, where 90.5% of issued shares were represented. Shareholders approved the election of eight directors, the compensation of named executive officers, and the appointment of Deloitte & Touche LLP as independent auditors for fiscal 2026.
The most recent analyst rating on (SCSC) stock is a Hold with a $43.00 price target. To see the full list of analyst forecasts on ScanSource stock, see the SCSC Stock Forecast page.